MX9207114A - Derivados de 4-pirimidinil y piridinil de indol-3-il-alquil piperazinas y composicion farmaceutica que los contiene. - Google Patents

Derivados de 4-pirimidinil y piridinil de indol-3-il-alquil piperazinas y composicion farmaceutica que los contiene.

Info

Publication number
MX9207114A
MX9207114A MX9207114A MX9207114A MX9207114A MX 9207114 A MX9207114 A MX 9207114A MX 9207114 A MX9207114 A MX 9207114A MX 9207114 A MX9207114 A MX 9207114A MX 9207114 A MX9207114 A MX 9207114A
Authority
MX
Mexico
Prior art keywords
derivatives
piperazinas
pirimidinil
piridinil
alquil
Prior art date
Application number
MX9207114A
Other languages
English (en)
Inventor
David W Smith
Frank D Yocca
Joseph P Yevich
Ronald J Mattson
Andrew Williams Edwar Ruediger
Keith Dean Combrink
Bradley Clyde Pearce
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of MX9207114A publication Critical patent/MX9207114A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

La presente invención se refiere a nuevos derivados de alcoxipiridin-4-ilo y alcoxipirimidin-4-ilo de indol-3-ilalquilpiperazinas que son útiles como agentes para aliviar los dolores de cabeza vasculares, en base a su potente afinidad y actividad agonista en los sitios de enlace o unión del 5-HTlD.
MX9207114A 1991-12-19 1992-12-09 Derivados de 4-pirimidinil y piridinil de indol-3-il-alquil piperazinas y composicion farmaceutica que los contiene. MX9207114A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81066191A 1991-12-19 1991-12-19
US95959292A 1992-10-13 1992-10-13

Publications (1)

Publication Number Publication Date
MX9207114A true MX9207114A (es) 1993-07-01

Family

ID=27123378

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9207114A MX9207114A (es) 1991-12-19 1992-12-09 Derivados de 4-pirimidinil y piridinil de indol-3-il-alquil piperazinas y composicion farmaceutica que los contiene.

Country Status (15)

Country Link
US (1) US5434154A (es)
EP (1) EP0548813A1 (es)
JP (1) JPH05262762A (es)
CN (1) CN1085556A (es)
AU (1) AU661527B2 (es)
CA (1) CA2084531A1 (es)
CZ (1) CZ359292A3 (es)
FI (1) FI925737A (es)
IL (1) IL104024A (es)
MX (1) MX9207114A (es)
NO (1) NO302522B1 (es)
NZ (1) NZ245439A (es)
PH (1) PH30988A (es)
RU (1) RU2114111C1 (es)
TW (1) TW221420B (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5521188A (en) * 1993-09-16 1996-05-28 Bristol-Myers Squibb Company Antimigraine cyclobutenedione derivatives of indolylalkyl-pyridinyl and pyrimidinylpiperazines
CA2130078A1 (en) * 1993-09-16 1995-03-17 Jonas A. Gylys Antimigraine cyclobutenedione derivatives of indolylalkyl-pyridinyl and pyrimidinylpiperazines
US5468768A (en) * 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antimigraine derivatives of indolylcycloalkanylamines
US5807857A (en) * 1994-05-19 1998-09-15 Merck Sharp & Dohme Ltd. Piperazine, piperidine and tetrahydropyridine derivative of indol-3-alkyl as 5-HT1D-α agonists
US5552402A (en) * 1994-05-19 1996-09-03 Merck, Sharp & Dohme Ltd. Five-membered heteroaromatic compounds as 5-HT receptor agonists
GB9410031D0 (en) * 1994-05-19 1994-07-06 Merck Sharp & Dohme Therapeutic agents
US5567824A (en) * 1994-05-24 1996-10-22 Merck & Co., Inc. Palladium catalyzed ring closure of triazolyltryptamine
ES2079323B1 (es) * 1994-06-21 1996-10-16 Vita Invest Sa Derivados de indol utiles para el tratamiento de la migraña, composicion y uso correspondientes.
GB9415575D0 (en) * 1994-08-02 1994-09-21 Merck Sharp & Dohme Therapeutic agents
US5550239A (en) * 1994-11-08 1996-08-27 Bristol-Myers Squibb Company Process for large-scale production of indolyl alkyl pyrimidinyl piperazine compounds
GB9423682D0 (en) * 1994-11-23 1995-01-11 Merck Sharp & Dohme Therapeutic agents
US5981529A (en) * 1995-01-15 1999-11-09 Merck Sharp & Dohme Limited Substituted indolylpropyl-piperazine derivatives as 5-HT1D α agonists
GB9501865D0 (en) * 1995-01-31 1995-03-22 Merck Sharp & Dohme Therapeutic agents
US5618816A (en) * 1995-03-02 1997-04-08 Bristol-Myers Squibb Company Antimigraine 1,2,5-thiadiazole derivatives of indolylalkyl-pyridnyl and pyrimidinylpiperazines
US5889010A (en) * 1995-05-18 1999-03-30 Pfizer Inc. Benzimidazole derivatives having dopaminergic activity
US5889008A (en) * 1995-08-07 1999-03-30 Merck Sharp & Dohme, Ltd. Substituted 1-indolylpropyl-4-phenethylpiperazadine derivatives
JPH09124643A (ja) * 1995-08-14 1997-05-13 Bristol Myers Squibb Co 抗うつ作用を有する１−アリールアルキル−４−（アルコキシピリジニル）−又は４−（アルコキシピリミジニル）ピペラジン誘導体
GB9519563D0 (en) * 1995-09-26 1995-11-29 Merck Sharp & Dohme Therapeutic agents
AU7319096A (en) * 1995-11-02 1997-05-22 Merck Sharp & Dohme Limited Bicyclic heteroaryl-alkylene-(homo)piperazinones and thione analogues thereof, their preparation and their use as selective agonists of 5-ht1-like receptors
GB9523250D0 (en) * 1995-11-14 1996-01-17 Merck Sharp & Dohme Therapeutic agents
GB9609374D0 (en) * 1996-05-03 1996-07-10 Merck Sharp & Dohme Therapeutic agents
US5877329A (en) * 1996-08-13 1999-03-02 Merck & Co., Inc. Palladium catalyzed indolization
US5808064A (en) * 1996-08-13 1998-09-15 Merck & Co., Inc. Palladium catalyzed indolization
US5811551A (en) * 1996-08-13 1998-09-22 Merck & Co., Inc. Palladium catalyzed indolization
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
GB9714383D0 (en) * 1997-07-08 1997-09-10 Pfizer Ltd Improved process
DE19756036A1 (de) 1997-12-17 1999-06-24 Merck Patent Gmbh Amid- und Harnstoffderivate
ATE374192T1 (de) * 2000-11-29 2007-10-15 Lilly Co Eli 1-(2-m-methansulfonamidophenylethyl)-4-(m- trifluoromethylphenyl)piperazine und ihre akzeptablen pharmazeutischen salze und solvate und ihre verwendung zur behandlung von inkontinenz
US6685951B2 (en) 2001-07-05 2004-02-03 R. T. Alamo Ventures I, Inc. Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine
US20030198669A1 (en) * 2001-07-05 2003-10-23 R.T. Alamo Ventures I, Llc Compositions and methods for rapid dissolving formulations of dihydroergotamine and caffeine for the treatment of migraine
US20030017175A1 (en) * 2001-07-05 2003-01-23 R.T. Alamo Ventures I, Inc. Sublingual administration of dihydroergotamine for the treatment of migraine
US7407983B2 (en) 2002-02-13 2008-08-05 Meiji Dairies Corporation Indole derivatives substituted with long-chain alcohols and medicaments containing them
WO2006129190A1 (en) * 2005-06-03 2006-12-07 Glenmark Pharmaceuticals Limited Process for the preparation of almotriptan
RU2461556C2 (ru) * 2006-12-30 2012-09-20 Эбботт Гмбх Унд Ко. Кг Замещенные производные оксидола и их применение в качестве лигандов рецептора вазопрессина
KR20150041804A (ko) 2007-02-11 2015-04-17 맵 파마슈티컬스, 인코포레이티드 부작용 프로파일을 최소화하면서 편두통의 빠른 완화를 가능하게 하는 ｄｈｅ의 치료적 투여 방법
EP2036888A1 (en) * 2007-09-17 2009-03-18 Laboratorios del Dr. Esteve S.A. Naphthyl-substituted sulfonamides
PL2734634T3 (pl) 2011-07-22 2020-03-31 The University Of Chicago Igf-1 do zastosowania do leczenia migreny
CA2895816C (en) 2012-12-21 2021-02-23 Map Pharmaceuticals, Inc. 8'-hydroxy-dihydroergotamine compounds and compositions
CN104163813B (zh) * 2013-05-16 2017-02-01 广东东阳光药业有限公司 取代的吲哚化合物及其使用方法和用途
EP3027607B1 (en) 2013-07-29 2020-08-26 Sunshine Lake Pharma Co., Ltd. Substituted heteroaryl compounds and methods of use thereof
CN104725359B (zh) * 2013-12-20 2017-05-03 广东东阳光药业有限公司 取代的哌嗪化合物及其使用方法和用途
CN104725363B (zh) * 2013-12-20 2019-03-01 广东东阳光药业有限公司 取代的哌嗪化合物及其使用方法和用途
CN106243088B (zh) * 2015-06-03 2019-01-04 广东东阳光药业有限公司 取代的哌嗪化合物及其使用方法和用途
AU2018354972B2 (en) * 2017-10-27 2021-07-08 Fresenius Kabi Oncology Ltd. An improved process for the preparation of ribociclib and its salts

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB944443A (es) * 1959-09-25 1900-01-01
GB1189064A (en) 1967-05-01 1970-04-22 Sterling Drug Inc Indole Derivatives
IT1170387B (it) 1982-06-07 1987-06-03 Glaxo Group Ltd Composti eterociclici, procedimento per prepararli e composizioni farmaceutiche che li contengono
GB2162522B (en) 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
US4954502A (en) * 1988-06-10 1990-09-04 Bristol-Myers Squibb Company 1-indolyalkyl-4-(substituted-pyridinyl)piperazines
FR2635104B1 (fr) 1988-08-03 1992-04-30 Synthelabo Derives d'indolone, leur preparation et leur application en therapeutique
GB8830312D0 (en) 1988-12-28 1989-02-22 Lundbeck & Co As H Heterocyclic compounds
JP2871811B2 (ja) 1990-02-28 1999-03-17 サントリー株式会社 縮合７員環系化合物
US5077293A (en) * 1990-06-29 1991-12-31 Bristol-Myers Squibb Co. 1-indolyalkyl-4-(alkoxypyrimidinyl)piperazines
CA2043709C (en) * 1990-06-29 2002-01-22 David W. Smith Antimigraine alkoxypyrimidine derivatives

Also Published As

Publication number Publication date
AU3003492A (en) 1994-03-24
NO302522B1 (no) 1998-03-16
CZ359292A3 (en) 1994-01-19
JPH05262762A (ja) 1993-10-12
NZ245439A (en) 1995-07-26
CA2084531A1 (en) 1993-06-20
NO924764D0 (no) 1992-12-10
EP0548813A1 (en) 1993-06-30
TW221420B (es) 1994-03-01
NO924764L (no) 1993-06-21
PH30988A (en) 1997-12-23
US5434154A (en) 1995-07-18
IL104024A (en) 1997-04-15
RU2114111C1 (ru) 1998-06-27
FI925737A (fi) 1993-06-20
AU661527B2 (en) 1995-07-27
FI925737A0 (fi) 1992-12-17
CN1085556A (zh) 1994-04-20

Similar Documents

Publication Publication Date Title
MX9207114A (es) Derivados de 4-pirimidinil y piridinil de indol-3-il-alquil piperazinas y composicion farmaceutica que los contiene.
ES2058185T3 (es) Derivados de camptotecina y procedimiento para su preparacion.
ES2059446T3 (es) Composicion de copolimero bloque hidrogenado especifico y procedimiento para su fabricacion.
SV1997000009A (es) Nuevas oxazolidinonas sustituidas ref. lea 31534-sv
ES2184797T3 (es) Uso de antagonistas de serotonina (5ht3) para el tratamiento de la fibromialgia.
MX9203647A (es) Materiales absorbentes y metodos para su produccion.
MX17808A (es) Nuevos derivados de artemisinina,procedimiento para su preparacion y su uso como agentes antiprosoos
ES2035668T3 (es) Uso de moleculas de adherencia intercelular y sus ligandos de union en el tratamiento del asma.
MX24890A (es) Polipeptido sintetico, procedimiento par su preparacion y composicion farmaceutica que lo contiene.
ES2013585A4 (es) Derivados de granadina que tienen actividad hipotensiva, composicion que los contiene, y proceso para su produccion
ES2104917T3 (es) Bis-naftalimidas que contienen engarces amido y tioamido como agentes anticancerosos.
ES2100263T3 (es) Nuevas isohirudinas sinteticas con estabilidad mejorada.
SV1997000010A (es) Nuevas heteroariloxazolidinonas ref. lea 31535-sv
ES525297A0 (es) Procedimiento para la obtencion de derivados de terc.-butanol sustituidos
FI883370A (fi) Vaakasuuntainen, voima-avusteinen nahanlevityspöytä
ES2098263T3 (es) 8-alfa-acilamino-ergolinas, su preparacion y su utilizacion como medicamentos.
ES488301A0 (es) Procedimiento para la obtencion de dehidropeptidos
ES2072869T3 (es) Uso de derivados de la 1,4-dihidropiridina en el tratamiento del alcoholismo.
FI961339A0 (fi) Triaryylieteenijohdannaiset käytettäväksi hoidossa
NO985079L (no) Eksplosiv formulering
MX9206365A (es) Tetrahidrobenzotienopiridinas,proceso para su preparacion y composicion farmaceutica que las contiene
DE58907569D1 (de) Isomere Trimethylbicyclo[4.3.0]nonan-Derivate.
MX9307679A (es) Derivados de furanona utiles en terapia.
IT1141080B (it) L'applicazione in terapuetica come agenti analgesici dei derivati del 4,5,6,7-tetraidroisossazolo (5,4-c)piridin-3-ol
ES2058179T3 (es) Tioeteres fenolicos como inhibidores de 5-lipoxigenasa.